Literature DB >> 19059724

Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.

Yasuyuki Goto1, Randall F Howard, Ajay Bhatia, Joelma Trigo, Maria Nakatani, Eduardo M Netto, Steven G Reed.   

Abstract

Leishmania infantum is a causative agent of endemic zoonotic visceral leishmaniasis (VL) in regions of South America and the Mediterranean. Dogs are the major reservoirs for L. infantum in these regions, and control of disease in dogs could have a significant impact on human disease. Although dogs share many symptoms of VL with humans as a result of L. infantum infection, they also show some unique clinical manifestations, which are often a combination of visceral and cutaneous leishmaniasis, suggesting different mechanisms of disease development in dogs and humans. Here, we compare antibody responses of dogs and humans with VL to various defined leishmanial antigens. Parasite lysate and K39, the two most commonly used antigens for serodiagnosis of VL, detected the highest levels of antibodies in both humans and dogs with VL, whereas the recognition patterns of these antigens were distinct between the hosts. Among other defined antigens tested, LmSTI1 and CPB detected higher levels of antibodies in dogs and humans, respectively. These results indicate there is a difference between humans and dogs in antigen recognition patterns during VL. We infer that different strategies may need to be used in development of vaccines and diagnostics for humans and for dogs. In addition, we show a correlation between antibody titers to several antigens and severity of clinical symptoms during canine VL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059724      PMCID: PMC2947490          DOI: 10.1016/j.vetpar.2008.10.097

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  36 in total

1.  Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.

Authors:  S Stäger; D F Smith; P M Kaye
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 2.  Canine leishmaniasis: novel strategies for control.

Authors:  Richard Reithinger; Clive R Davies
Journal:  Trends Parasitol       Date:  2002-07

3.  Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections.

Authors:  A Ghosh; W W Zhang; G Matlashewski
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

Review 4.  Canine leishmaniasis: epidemiological risk and the experimental model.

Authors:  Javier Moreno; Jorge Alvar
Journal:  Trends Parasitol       Date:  2002-09

Review 5.  Diagnosis of canine visceral leishmaniasis: biotechnological advances.

Authors:  Y M Gomes; M Paiva Cavalcanti; R A Lira; F G C Abath; L C Alves
Journal:  Vet J       Date:  2006-12-05       Impact factor: 2.688

6.  Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease.

Authors:  A Campos-Neto; R Porrozzi; K Greeson; R N Coler; J R Webb; Y A Seiky; S G Reed; G Grimaldi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial.

Authors:  A S Mazloumi Gavgani; M H Hodjati; H Mohite; C R Davies
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

8.  Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis.

Authors:  Sima Rafati; Alireza Nakhaee; Tahere Taheri; Andishe Ghashghaii; Ali Hatef Salmanian; Maribel Jimenez; Mehdi Mohebali; Slavica Masina; Nicolas Fasel
Journal:  Exp Parasitol       Date:  2003 Mar-Apr       Impact factor: 2.011

Review 9.  Chemotherapy of canine leishmaniosis.

Authors:  Gad Baneth; Susan E Shaw
Journal:  Vet Parasitol       Date:  2002-07-02       Impact factor: 2.738

10.  Rapid detection of Leishmania infantum infection in dogs: comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR.

Authors:  Richard Reithinger; Rupert J Quinnell; Bruce Alexander; Clive R Davies
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more
  16 in total

1.  KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.

Authors:  Yasuyuki Goto; Ajay Bhatia; Vanitha S Raman; Hong Liang; Raodoh Mohamath; Alessandro F Picone; Silvia E Z Vidal; Thomas S Vedvick; Randall F Howard; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2011-06-01

2.  Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasis.

Authors:  Geraldo G S Oliveira; Franklin B Magalhães; Márcia C A Teixeira; Andrea M Pereira; Cristiane G M Pinheiro; Lenita R Santos; Marília B Nascimento; Cheila N G Bedor; Alessandra L Albuquerque; Washington L C dos-Santos; Yara M Gomes; Edson D Moreira; Maria E F Brito; Lain C Pontes de Carvalho; Osvaldo P de Melo Neto
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

3.  Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine.

Authors:  Rajiv Kumar; Yasuyuki Goto; Kamlesh Gidwani; Karen D Cowgill; Shyam Sundar; Steven G Reed
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

Authors:  Joelma Trigo; Melissa Abbehusen; Eduardo M Netto; Maria Nakatani; Geraldo Pedral-Sampaio; Robson Silva de Jesus; Yasuyuki Goto; Jeffrey Guderian; Randall F Howard; Steven G Reed
Journal:  Vaccine       Date:  2010-03-04       Impact factor: 3.641

5.  Human antibody response to thioredoxin peroxidase-1 and tandem repeat proteins as immunodiagnostic antigen candidates for Schistosoma japonicum infection.

Authors:  Jose Ma Angeles; Yasuyuki Goto; Masashi Kirinoki; Lydia Leonardo; Pilarita Tongol-Rivera; Elena Villacorte; Noboru Inoue; Yuichi Chigusa; Shin-ichiro Kawazu
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

6.  Upregulated expression of B-cell antigen family tandem repeat proteins by Leishmania amastigotes.

Authors:  Yasuyuki Goto; Darrick Carter; Jeffrey Guderian; Noboru Inoue; Shin-Ichiro Kawazu; Steven G Reed
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

7.  Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis.

Authors:  Nuno Santarém; Ricardo Silvestre; Luís Cardoso; Henk Schallig; Steven G Reed; Anabela Cordeiro-da-Silva
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

8.  Biased cellular locations of tandem repeat antigens in African trypanosomes.

Authors:  Yasuyuki Goto; Malcolm S Duthie; Shin-Ichiro Kawazu; Noboru Inoue; Darrick Carter
Journal:  Biochem Biophys Res Commun       Date:  2011-01-15       Impact factor: 3.575

9.  Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.

Authors:  Eduardo A F Coelho; Laura Ramírez; Mariana A F Costa; Vinicio T S Coelho; Vivian T Martins; Miguel A Chávez-Fumagalli; Dulcilene M Oliveira; Carlos A P Tavares; Pedro Bonay; Carlos Gómez Nieto; Daniel R Abánades; Carlos Alonso; Manuel Soto
Journal:  Clin Vaccine Immunol       Date:  2009-10-07

10.  Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach.

Authors:  Vinicio T S Coelho; Jamil S Oliveira; Diogo G Valadares; Miguel A Chávez-Fumagalli; Mariana C Duarte; Paula S Lage; Manuel Soto; Marcelo M Santoro; Carlos A P Tavares; Ana Paula Fernandes; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.